Breast Health Solutions

Accuracy accelerated.

Detection delivered.

Powered by AI.

iCAD's Breast Health Solutions are built on deep learning technology and deliver powerful software solutions for breast tomosynthesis, breast density, risk assessment and 2D mammography. These innovative solutions offer clinicians a wide range of tools for disease detection and analysis that enhance workflow and improve overall efficiency. Our Breast Health Solutions support healthcare facilities worldwide in providing quality breast care to their patients.

​Breast AI SuiteContact UsCustomer Support

ProFound AI® for Digital Breast Tomosynthesis

The Clear Leader in Breast AI.
Superior Accuracy and Performance.
A ProFound Evolution.

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-reaReading digital breast tomosynthesis (DBT) cases means being able to accurately interpret extensive amounts of data.  Clinicians are confronted by the workload and time required to accurately read the data contained in DBT cases.

ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-read, cancer-detection and workflow solution that rapidly and accurately analyzes each tomosynthesis image, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy.

*iCAD data on file. Standalone performance varies by vendor.

Learn More>

ProFound AI® Risk

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that isNow available for 3D mammography, ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate short-term, breast cancer risk estimation that is truly personalized for each woman, based only on a screening mammogram.1

The easy-to-implement solution provides superior insights1 that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier.

ProFound AI Risk uniquely combines a range of risk factors, offering superior performance in assessing short-term risk compared to traditional breast cancer risk models.1

Learn More>

 

References:

  1. Eriksson M, Czene K, Strand F, et al. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. [published online ahead of print September 8, 2020]. Radiology. Accessed via https://doi.org/10.1148/radiol.2020201620

PowerLook® Density Assessment

PowerLook® Density Assessment is an automated breast density solution that is designed to standardize the assessment of breast density in 2D anNew and improved: PowerLook® Density Assessment is the world’s first and only deep-learning multi-vendor automated breast density assessment algorithm for synthesized 2D images.

This solution uses an appearance-based approach to assess dense tissue, to deliver automated, rapid and reproducible assessments of breast structure, texture, and fibroglandular dispersion, with greater accuracy than ever before. This innovative technique calibrates the patient’s breast density to the appropriate density category corresponding to BI-RADS reporting system.

*For GE and Hologic only. Uses 2D synthesized images

Learn More>

ProFound AI® Solutions - EU

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultaneThe Complete Artificial Intelligence Solution for Breast Cancer Screening

ProFound AI is a high-performance, deep-learning workflow solution trained to detect malignant soft-tissue densities and calcifications.  With thousands of installations around the world, ProFound AI offers multi-vendor compatibility and seamlessly integrates into the diagnostic process.

CE Marked

Learn More>

SecondLook® for 2D Mammography

SecondLook is based on sophisticated patented algorithms that analyze the data, automatically identifying and marking suspicious regions in 2DSecondLook® is based on sophisticated patented algorithms that analyze the data, automatically identifying and marking suspicious regions in 2D mammography images. The solution provides the radiologist with a “second look” which helps the radiologist detect actionable missed cancers earlier than screening mammography alone. SecondLook detects and identifies suspicious masses and micro-calcifications utilizing image processing, pattern recognition and artificial intelligence techniques. Information from thousands of mammography images are incorporated into these algorithms enabling the product to distinguish between characteristics of cancerous and normal tissue.

Learn More>

© iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

Facebook icon Twitter icon LinkedIn icon

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-rea

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultane

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-rea

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultane

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-rea

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultane

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-rea

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultane

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-rea

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultane

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-rea

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultane

ProFound AI for Digital Breast Tomosynthesis: ProFound AI® is raising the bar on detection performance.  It is a high-performing, concurrent-rea

ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is

ProFound AI is proven to assist radiologists in addressing the challenges of reading cases by improving cancer detection rates, while simultane